Shennon Biotechnologies
Develops a single-cell platform for rapid immunotherapy drug discovery.
biotechpharmaceuticals
Company facts
Seed-stage
- Founded
- 2021
- Employees
- 16
- Headquarters
- United States
- Type
- Private
- Funding
- Seed · $13M · 2023
Open positions
1 job
4 views 3 weeks ago
Head of Droplet-based Microfluidics Applications - Associate Director
Open 35d North AmericaC-level 4 questions
United States
San Francisco, CAAbout Us: Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional…